Centocor Ortho Biotech v. Abbott Labs & NYU

CAFC Decision Overturning $1.6 Billion Verdict

more+
less-

Despite jury award of $1.6 Billion in damages, the CAFC held the patent invalid for failure to have satisfied the "written description" requirement that would have demonstrated that the inventors had "possession" of the biotech invention claimed, at the time he invenition was made.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Intellectual Property Updates

Reference Info:Decision | Federal, Federal Circuit, Patent | United States